what to do with braf-mutant melanoma patients who have a poor prognosis?
Published 7 years ago • 129 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
2:58
role of braf mutation in the treatment for melanoma
-
3:08
os rates and prognostic categories for braf-mutated melanoma when treated with combination therapy
-
4:18
development of novel treatments in melanoma patients with braf mutations
-
2:10
using biomarkers to predict response to combination therapies in braf-mutant melanoma
-
2:29
braf mutated melanoma: targeted or immunotherapy?
-
27:28
advances in therapy for braf-mutant melanoma
-
1:17
treatment selection for stage iii braf-mutant melanoma
-
17:51
how to approach the patient with a braf mutant tumor
-
2:56
treating braf v600e-mutant nsclc with dabrafenib and trametinib
-
5:58
who should be tested for the braf mutation?
-
22:40
how to approach the patient with braf mutant tumor
-
10:08
emerging approaches for braf-mutant metastatic melanoma
-
22:44
braf targeted therapy - melanoma education symposium, peter boasberg md
-
1:23
braf in melanoma explained
-
6:22
braf and mek in melanoma
-
1:01:29
new rules for sequential care in braf-mutated melanoma
-
5:31
treating braf-mutated metastatic melanoma
-
6:08
braf-mutant melanoma: frontline decisions
-
2:10
combined treatment with braf and mek inhibitors in metastatic melanomas with braf mutations